Calaspargase Pegol-mknl
Category: CancerCalaspargase Pegol-mknl Overview
Calaspargase pegol, sold under the brand name Asparlas, is a medication for the treatment of acute lymphoblastic leukemia (ALL). It is approved in the United States as a component of a multi-agent chemotherapeutic regimen for ALL in pediatric and young adult patients aged one month to 21 years.[2] Calaspargase pegol is an engineered protein consisting of the E. coli-derived enzyme L-asparaginase II conjugated with succinimidyl carbonate monomethoxypolyethylene glycol (pegol)....
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Calaspargase_pegol-mknl
Recent Calaspargase Pegol-mknl Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Calaspargase Pegol-mknl
- Injection: 3750units/5ml
Other drugs which contain Calaspargase Pegol-mknl or a similar ingredient: (1 result)
- ASPARLAS Calaspargase Pegol-mknl